<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id><journal-title-group>
<journal-title>PLoS Computational Biology</journal-title></journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-13-00666</article-id>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1003328</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories>
<title-group>
<article-title>A Data-Driven Mathematical Model of CA-MRSA Transmission among Age Groups: Evaluating the Effect of Control Interventions</article-title>
<alt-title alt-title-type="running-head">Modeling CA-MRSA Transmission</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Xiaoxia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Panchanathan</surname><given-names>Sarada</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chowell</surname><given-names>Gerardo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Mathematical, Computational and Modeling Sciences Center, School of Human Evolution and Social Change, Arizona State University, Tempe, Arizona, United States of America</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Pediatrics, Maricopa Integrated Health System, Phoenix, Arizona, United States of America</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Biomedical Informatics, Arizona State University, Tempe, Arizona, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Salathé</surname><given-names>Marcel</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Pennsylvania State University, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">xwang248@asu.edu</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: XW SP GC. Performed the experiments: XW. Analyzed the data: XW. Contributed reagents/materials/analysis tools: XW SP GC. Wrote the paper: XW GC.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>11</month><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>21</day><month>11</month><year>2013</year></pub-date>
<volume>9</volume>
<issue>11</issue>
<elocation-id>e1003328</elocation-id>
<history>
<date date-type="received"><day>19</day><month>4</month><year>2013</year></date>
<date date-type="accepted"><day>24</day><month>9</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" xlink:type="simple"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" xlink:type="simple">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions>
<abstract>
<p>Community associated methicillin-resistant <italic>Staphylococcus aureus</italic> (CA-MRSA) has become a major cause of skin and soft tissue infections (SSTIs) in the US. We developed an age-structured compartmental model to study the spread of CA-MRSA at the population level and assess the effect of control intervention strategies. We used Monte-Carlo Markov Chain (MCMC) techniques to parameterize our model using monthly time series data on SSTIs incidence in children (≤19 years) during January 2004 -December 2006 in Maricopa County, Arizona. Our model-based forecast for the period January 2007–December 2008 also provided a good fit to data. We also carried out an uncertainty and sensitivity analysis on the control reproduction number, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e001" xlink:type="simple"/></inline-formula> which we estimated at 1.3 (95% CI [1.2,1.4]) based on the model fit to data. Using our calibrated model, we evaluated the effect of typical intervention strategies namely reducing the contact rate of infected individuals owing to awareness of infection and decolonization strategies targeting symptomatic infected individuals on both <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e002" xlink:type="simple"/></inline-formula> and the long-term disease dynamics. We also evaluated the impact of hypothetical decolonization strategies targeting asymptomatic colonized individuals. We found that strategies focused on infected individuals were not capable of achieving disease control when implemented alone or in combination. In contrast, our results suggest that decolonization strategies targeting the pediatric population colonized with CA-MRSA have the potential of achieving disease elimination.</p>
</abstract>
<abstract abstract-type="summary"><title>Author Summary</title>
<p>Community associated methicillin-resistant <italic>Staphylococcus aureus</italic> (CA-MRSA) is a bacteria that causes skin infections in the US. We developed a mathematical model of CA-MRSA transmission among different age groups at the population level. We parameterized the model using monthly time series data on number of SSTIs in children during the period January 2004–December 2006 in Maricopa County, Arizona. Our model-based forecast to additional time series data covering the period 2007–2008 yielded a good fit to data. Using our calibrated model, we calculated that an infected individual generates on average 1.3 infected people in a totally susceptible population in the study area. We assessed the impact of intervention strategies including reductions in contact rates between infected and non-infected individuals and the effect of decolonization strategies aimed at infected individuals by drug treatment, and found that neither of the two strategies when implemented alone or in combination were able to control the disease. In contrast, we found that decolonization strategies targeting the pediatric population colonized with CA-MRSA have the potential of achieving disease elimination.</p>
</abstract>
<funding-group><funding-statement>This work was supported by the Arizona Biomedical Research Commission (<ext-link ext-link-type="uri" xlink:href="http://azdhs.gov/biomedical/" xlink:type="simple">http://azdhs.gov/biomedical/</ext-link>) with Commission Contract No. 1216. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="13"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<sec id="s1a">
<title>Background</title>
<p><italic>Staphylococcus aureus</italic> is one of the most common bacterial pathogens in humans and the most frequent cause of skin and soft tissue infections (SSTIs) <xref ref-type="bibr" rid="pcbi.1003328-Lowy1">[1]</xref>. Strains of health care-associated methicillin-resistant <italic>S. aureus</italic> (HA-MRSA) were first identified among hospitalized patients in 1960 <xref ref-type="bibr" rid="pcbi.1003328-Jevons1">[2]</xref> and dominated MRSA infections until late 1980s. Since the early 1990s, there has been a dramatic increase in community-associated MRSA (CA-MRSA), which is now endemic at unprecedented levels in many regions in the US <xref ref-type="bibr" rid="pcbi.1003328-Purcell1">[3]</xref>–<xref ref-type="bibr" rid="pcbi.1003328-Pallin1">[6]</xref>. This increase in CA-MRSA appears to have regional variation and is more pronounced in children compared to adults <xref ref-type="bibr" rid="pcbi.1003328-Dukic1">[4]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-Bratu1">[5]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-Popovich1">[7]</xref>. Cases of HA-MRSA and CA-MRSA are characterized by significantly different epidemiological and microbiological features <xref ref-type="bibr" rid="pcbi.1003328-Naimi1">[8]</xref>.</p>
<p>Evidence indicates that CA-MRSA infections result from physical contacts with MRSA carriers at home, community facilities such as gyms, nursing homes, or kindergartens <xref ref-type="bibr" rid="pcbi.1003328-David1">[9]</xref>. In addition to regular treatment of the actual infection of the infected individuals, typical intervention strategies against CA-MRSA related SSTIs focus on pharmaceutical treatment via decolonization using mupirocin <xref ref-type="bibr" rid="pcbi.1003328-Doebbeling1">[10]</xref>–<xref ref-type="bibr" rid="pcbi.1003328-VanRijen1">[12]</xref> and reductions in contact rates between infected and non-infected individuals. However, the role of these control interventions on CA-MRSA transmission dynamics remains poorly understood. In particular, in this paper we asked if control strategies targeting symptomatic infected individuals were sufficient to achieve disease control in a population.</p>
<p>Although several mathematical models for MRSA transmission in hospital settings, nursing homes, and other inpatient facilities have been developed (e.g., <xref ref-type="bibr" rid="pcbi.1003328-MCDAgata1">[13]</xref>–<xref ref-type="bibr" rid="pcbi.1003328-Wassenberg1">[18]</xref>), there is a scarcity of transmission models of MRSA and relevant epidemiological data to parameterize them at the community level, but these could be useful to elucidate the transmission dynamics and the effect of control interventions on CA-MRSA. For instance, in <xref ref-type="bibr" rid="pcbi.1003328-MCDAgata1">[13]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-DAgata1">[14]</xref> and <xref ref-type="bibr" rid="pcbi.1003328-Kouyos1">[19]</xref>, compartmental transmission models were developed to study the invasion of CA-MRSA into hospitals and the likelihood of coexistence between CA-MRSA and hospital-acquired (HA-) MRSA. Moreover, HA-MRSA dynamics were exclusively studied in both <xref ref-type="bibr" rid="pcbi.1003328-Chamchod1">[16]</xref> and <xref ref-type="bibr" rid="pcbi.1003328-Chamchod2">[17]</xref>. In these studies, health care workers were modeled as vectors transmitting disease among patients (or residents) with the goal of assessing the impact of quantifying the effect of targeted control measures. Furthermore, most of these modeling studies have assumed homogenous mixing, but recent work has pointed to age-specific variation in MRSA infection risk <xref ref-type="bibr" rid="pcbi.1003328-Dukic1">[4]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-Milstone1">[20]</xref>. Hence, age-structured CA-MRSA transmission models at the community level and tailored to local epidemiological data could increase our understanding of the transmission dynamics of CA-MRSA and the impact of routine and novel intervention strategies.</p>
<p>Here we developed and parameterized an age-structured compartmental transmission model to study the transmission dynamics of CA-MRSA at the population level and evaluate the effect of various intervention strategies. To calibrate the model, we employed a unique dataset <xref ref-type="supplementary-material" rid="pcbi.1003328.s001">Dataset S1</xref>) covering several years of SSTIs incidence during the period January 2004–December 2006 in Maricopa County, Arizona. We also used additional incidence data for subsequent years 2007–2008 for validation purposes. Based on our calibrated model, we estimated the reproduction number denoting the average number of secondary infections generated by primary infectious individual <xref ref-type="bibr" rid="pcbi.1003328-Macdonald1">[21]</xref>–<xref ref-type="bibr" rid="pcbi.1003328-Diekmann1">[23]</xref> and evaluated the effect of contact rate reductions aimed at infected individuals owing to awareness of infection as well as decolonization treatment strategies targeting symptomatic infected individuals or the general (asymptomatic) colonized subpopulation.</p>
</sec><sec id="s1b">
<title>Epidemiological data</title>
<p>We obtained detailed data on CA-MRSA infections from the Center for Health Information Research (CHIR), which is a university-community partnership between Arizona State University and several Arizona providers, insurers and employers. The dataset (<xref ref-type="supplementary-material" rid="pcbi.1003328.s001">Dataset S1</xref>) comprises records on hospitalization and outpatients visits by children and teenagers (age≤19 years) enrolled in the Medicaid program of Arizona from January 1, 2004 to December 31, 2008. We extracted records of all encounters diagnosed with skin or soft tissue infection (SSTI) based on ICD 9 codes (680.xx-682.9x). Each record contains information about the type of infection (first-time infection or recurrent infection), age group, month and year of hospital or clinic visit, and whether the patient was treated with mupirocin. Our data are based on SSTIs related infections, with a stationary fraction of MRSA-related infections during our study period <xref ref-type="bibr" rid="pcbi.1003328-Panchanathan1">[24]</xref>. We also obtained population data by age groups for our study setting. An extended data description is given in <xref ref-type="supplementary-material" rid="pcbi.1003328.s003">Text S1</xref>.</p>
</sec></sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<sec id="s2a">
<title>Model description</title>
<p>We developed an SEIS (Susceptible-Exposed-Infected-Susceptible) transmission model that incorporates age heterogeneity in contact rates, infectiousness, and decolonization treatment rates. Our model also keeps track of individuals with past infections because these individuals have been observed to have a higher rate of infection compared to those with no past infections <xref ref-type="bibr" rid="pcbi.1003328-Panchanathan1">[24]</xref>, and we are interested in assessing the effect of age-specific variation in infectiousness and the effect of targeted interventions. Let <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e003" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e004" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e005" xlink:type="simple"/></inline-formula> be the respective number of susceptible, colonized (asymptomatic), and infected (symptomatic) individuals in age group <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e006" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e007" xlink:type="simple"/></inline-formula>) with no prior infections. Similarly, let <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e008" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e009" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e010" xlink:type="simple"/></inline-formula> be the corresponding epidemiological states for individuals with prior infection history. The schematic view of transitions among the 6 epidemiological states in our model for each age group is shown in <xref ref-type="fig" rid="pcbi-1003328-g001">Figure 1</xref>. Mupirocin is used for decolonization of CA-MRSA patients who have been treated by other antibiotics. Hence, in our model only decolonized individuals coming from the infected compartments experience the additional decolonization rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e011" xlink:type="simple"/></inline-formula>. Our transmission model is given by the following system of differential equations:<disp-formula id="pcbi.1003328.e012"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003328.e012" xlink:type="simple"/><label>(1a)</label></disp-formula><disp-formula id="pcbi.1003328.e013"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003328.e013" xlink:type="simple"/><label>(1b)</label></disp-formula><disp-formula id="pcbi.1003328.e014"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003328.e014" xlink:type="simple"/><label>(1c)</label></disp-formula><disp-formula id="pcbi.1003328.e015"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003328.e015" xlink:type="simple"/><label>(1d)</label></disp-formula><disp-formula id="pcbi.1003328.e016"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003328.e016" xlink:type="simple"/><label>(1e)</label></disp-formula><disp-formula id="pcbi.1003328.e017"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003328.e017" xlink:type="simple"/><label>(1f)</label></disp-formula>for <italic>a</italic> = 1, 2, …, <italic>n</italic>. The spontaneous (natural) decolonization rate per unit of time (month is denoted by <italic>d</italic><sub>0</sub>) and is assumed to be the same for all colonized individuals independently of their infection history. The progression rate from colonized to infected is <italic>τ</italic>0 for those colonized for the first time and <italic>τ</italic>1 for those with prior infections, where <italic>τ</italic>1&gt;<italic>τ</italic>0, with a relative risk factor <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e018" xlink:type="simple"/></inline-formula>. Infected individuals in compartments <italic>I</italic><sub>0</sub> and <italic>I</italic><sub>1</sub> progress to the colonization (with prior infections) stage (<italic>C</italic>1) following antibiotic treatment at a common cure rate <italic>γ</italic>. Further, treatment for decolonization aimed at <italic>C</italic>1 transfers individuals to compartment <italic>S</italic>1 at a decolonization rate <italic>d</italic><sub>1</sub>. Both colonized and infected individuals contribute to the force of infection, which is given by<disp-formula id="pcbi.1003328.e019"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003328.e019" xlink:type="simple"/><label>(1g)</label></disp-formula>where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e020" xlink:type="simple"/></inline-formula> denotes the contact rate for the colonized and infected individuals with susceptible individuals in age group <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e021" xlink:type="simple"/></inline-formula>. Moreover, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e022" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e023" xlink:type="simple"/></inline-formula> are the probabilities of transmission per contact (contagiousness) for colonized and infected individuals, respectively, which are assumed to be invariant across age groups. Because infected individuals are assumed to be more infectious than colonized individuals, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e024" xlink:type="simple"/></inline-formula>, with a relative contagiousness factor <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e025" xlink:type="simple"/></inline-formula>. Further, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e026" xlink:type="simple"/></inline-formula> is the population immigration/migration rate and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e027" xlink:type="simple"/></inline-formula> is the total population size with new recruits into the susceptible population with no past CA-MRSA infection history.</p>
<fig id="pcbi-1003328-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.g001</object-id><label>Figure 1</label><caption>
<title>Flow diagram for the compartment model of the transmission dynamics of CA-MRSA for each age group.</title>
<p><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e028" xlink:type="simple"/></inline-formula> is the number of susceptible people with no prior colonization with CA-MRSA, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e029" xlink:type="simple"/></inline-formula> is the number of people colonized for the first time, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e030" xlink:type="simple"/></inline-formula> are the number of people with first-time infection. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e031" xlink:type="simple"/></inline-formula> are individuals with a history of past infections. People with infections from both groups (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e032" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e033" xlink:type="simple"/></inline-formula>) become colonized (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e034" xlink:type="simple"/></inline-formula>) with a common cure rate (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e035" xlink:type="simple"/></inline-formula>). Further decolonization treatment (e.g. mupirocin) clears individuals and progress to the susceptible state (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e036" xlink:type="simple"/></inline-formula>). Susceptible individuals with or without past infections progress to the colonized stage with the same force of infection <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e037" xlink:type="simple"/></inline-formula>, but their progression rate from colonized to infected stages are different (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e038" xlink:type="simple"/></inline-formula> vs <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e039" xlink:type="simple"/></inline-formula>, respectively). Colonized individuals without past infections have only spontaneous decolonization with rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e040" xlink:type="simple"/></inline-formula> while those with past infections are subject to additional decolonization treatment with rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e041" xlink:type="simple"/></inline-formula>. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e042" xlink:type="simple"/></inline-formula> is the population immigration/migration rate per month.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.g001" position="float" xlink:type="simple"/></fig></sec><sec id="s2b">
<title>Parameters</title>
<sec id="s2b1">
<title>Age-specific contact rates</title>
<p>We stratified the population in our model into six age groups (years), 0–4, 5–9, 10–14, 15–19, 20–59, and 60+ yrs. The first four refined age groups are referred to as pediatric groups in this paper and are defined consistently with the age groups attending daycare/home-care, elementary school, junior high school, and high school in the US, respectively, as we are primarily interested in capturing the CA-MRSA transmission dynamics among young age groups. Contact rates across age groups were adapted from data on physical contacts previously derived from population surveys that were conducted in eight European countries <xref ref-type="bibr" rid="pcbi.1003328-Mossong1">[25]</xref> by collapsing the age groups 20–24, …, 55–59 into one adult group of age 20–59, and groups 60–64,65–69,70+ into a senior group 60+ yrs. following a similar approach as in <xref ref-type="bibr" rid="pcbi.1003328-Medlock1">[26]</xref> (<xref ref-type="fig" rid="pcbi-1003328-g002">Figure 2</xref>).</p>
<fig id="pcbi-1003328-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.g002</object-id><label>Figure 2</label><caption>
<title>Monthly contact rates among age groups (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e043" xlink:type="simple"/></inline-formula>).</title>
<p>Calculated from survey data on physical contacts from Mossong et al. <xref ref-type="bibr" rid="pcbi.1003328-Mossong1">[25]</xref>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.g002" position="float" xlink:type="simple"/></fig></sec><sec id="s2b2">
<title>Epidemiological parameters</title>
<p>The basic epidemiological parameters and baseline values are listed in <xref ref-type="table" rid="pcbi-1003328-t001">Table 1</xref>. Most of the initial (or most likely) values and ranges were obtained from a literature review while others were proposed by primary analysis of our epidemiological data. Specifically, we estimated the decolonization treatment coverage (or rate) (denoted as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e044" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e045" xlink:type="simple"/></inline-formula>) for each age group over the years by calculating the percentage of patients who were prescribed mupirocin (see <xref ref-type="supplementary-material" rid="pcbi.1003328.s003">Text S1</xref> for details). The overall age-specific decolonization rate, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e046" xlink:type="simple"/></inline-formula>, is then set to be the product of the treatment efficacy (percentage of successfully decolonized people among those who were prescribed mupirocin, denoted by <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e047" xlink:type="simple"/></inline-formula> in <xref ref-type="table" rid="pcbi-1003328-t001">Table 1</xref>), the age-specific treatment coverage <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e048" xlink:type="simple"/></inline-formula> (values are given by <xref ref-type="supplementary-material" rid="pcbi.1003328.s002">Table S1</xref>), and the reciprocal of the duration of the drug effect (about 2 weeks <xref ref-type="bibr" rid="pcbi.1003328-Doebbeling1">[10]</xref>). Moreover, we assumed higher transition rates from colonized to infected states for both first-time and recurrent infections for individuals 0–4 and 15–19 yrs., as there was a significantly higher number of cases for these two groups in our epidemiological data, which is in agreement with other empirical studies<xref ref-type="bibr" rid="pcbi.1003328-Vaska1">[27]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-Fridkin1">[28]</xref>. That is, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e049" xlink:type="simple"/></inline-formula> for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e050" xlink:type="simple"/></inline-formula> and 1, where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e051" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e052" xlink:type="simple"/></inline-formula> are the relative factors, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e053" xlink:type="simple"/></inline-formula> is the progression rate from colonized to infected for first-time (recurrent) infections for other age groups.</p>
<table-wrap id="pcbi-1003328-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.t001</object-id><label>Table 1</label><caption>
<title>Epidemiological parameters: definition, symbol, and initial value and range used in parameter estimation using the MCMC technique.</title>
</caption><alternatives><graphic id="pcbi-1003328-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Definition, unit</td>
<td align="left" rowspan="1" colspan="1">Parameter</td>
<td align="left" rowspan="1" colspan="1">Initial Value</td>
<td align="left" rowspan="1" colspan="1">Range</td>
<td align="left" rowspan="1" colspan="1">Reference</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">probability of transmission per contact with infected</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e054" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.0017</td>
<td align="left" rowspan="1" colspan="1">0.0009–0.0025</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003328-McBryde1">[44]</xref>, proposed</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">relative contagiousness factor for colonized to infected</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e055" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.25</td>
<td align="left" rowspan="1" colspan="1">0–0.5</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003328-Panchanathan1">[24]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">spontaneous decolonization rate, month<sup>−1</sup></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e056" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.09</td>
<td align="left" rowspan="1" colspan="1">0.02–0.8</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003328-Marschall1">[45]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-Konvalinka1">[46]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">efficacy of decolonization by mupirocin</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e057" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.8</td>
<td align="left" rowspan="1" colspan="1">0.5–1</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003328-Coates1">[47]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">progression rate from colonized to infected (baseline), month<sup>−1</sup></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e058" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.035</td>
<td align="left" rowspan="1" colspan="1">0.01–0.15</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003328-Panchanathan1">[24]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-Ellis1">[48]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">relative risk of infection (from colonized) for 0–4 age group</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e059" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">1.6</td>
<td align="left" rowspan="1" colspan="1">1.0–2.0</td>
<td align="left" rowspan="1" colspan="1">proposed</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">relative risk of infection (from colonized) for 15–19 age group</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e060" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">1.4</td>
<td align="left" rowspan="1" colspan="1">1.0–2.0</td>
<td align="left" rowspan="1" colspan="1">proposed</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">relative risk of progression rate from colonized to infected due to previous infection</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e061" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">2.5</td>
<td align="left" rowspan="1" colspan="1">2.0–8.0</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003328-Salgado1">[49]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">cure rate (1/(infection duration)), month<sup>−1</sup></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e062" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.25–1.5</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003328-Wassenberg1">[18]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-Panchanathan1">[24]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">immigration/migration rate, month<sup>−1</sup></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e063" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.0029</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003328-Bureau1">[50]</xref></td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>‘Proposed’ in reference column means proposed by primary analysis of the data.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s2c">
<title>Model calibration, validation and forecast</title>
<p>We calibrated our model given by System 0 with time series data of first time and recurrent infections for age groups 0–4, 5–9, 10–14, and 15–19 yrs. from January 2004 to December 2006 and estimated the unknown epidemiological parameters (<xref ref-type="table" rid="pcbi-1003328-t001">Table 1</xref>). For this purpose, we assumed as initial conditions that all people in the population were free of past infections in January 2004 (first time point). That is, we set to 0 the initial value for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e064" xlink:type="simple"/></inline-formula>, for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e065" xlink:type="simple"/></inline-formula>. The initial number of people with first-time infections in adult groups, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e066" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e067" xlink:type="simple"/></inline-formula>, as well as the percentage of completely susceptible people in each age group at the beginning of 2004, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e068" xlink:type="simple"/></inline-formula> (common across the age groups), were taken as unknown parameters to be estimated.</p>
<p>We employed a delayed rejection adaptive Metropolis-Hastings (DRAM) algorithm in a Markov-Chain Monte-Carlo (MCMC) simulation framework <xref ref-type="bibr" rid="pcbi.1003328-Haario1">[29]</xref> to estimate unknown model parameters. We used the widely-used MCMC package coded in Matlab (available from: <ext-link ext-link-type="uri" xlink:href="http://helios.fmi.fi/~lainema/mcmc/" xlink:type="simple">http://helios.fmi.fi/~lainema/mcmc/</ext-link>) (<xref ref-type="supplementary-material" rid="pcbi.1003328.s005">Text S3</xref>). For each estimated parameter we assumed uniform prior distributions with range values as given in <xref ref-type="table" rid="pcbi-1003328-t001">Table 1</xref>. Posterior distributions for each parameter were obtained from the resulting Markov chains <xref ref-type="bibr" rid="pcbi.1003328-Calvetti1">[30]</xref>. Next, we selected a random sample of size 500 from the Markov chain of parameters to assess parameter uncertainty. For model validation, we compared our calibrated model forecast for two subsequent years of time series data covering the period 2007–2008.</p>
<p>Latin Hypercube Sampling (LHS) and Partial Rank Correlation Coefficient (PRCC) techniques <xref ref-type="bibr" rid="pcbi.1003328-Blower1">[31]</xref> were used for sensitivity analysis to assess the impact of control strategies targeting different age groups on the reproduction number <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e069" xlink:type="simple"/></inline-formula>. LHS provides remarkable efficiency in drawing a highly representative random sample of small size from a multi-dimensional distribution<xref ref-type="bibr" rid="pcbi.1003328-Iman1">[32]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-McKay1">[33]</xref>. The magnitude of PRCC quantifies the importance of individual parameters, with the sign of the PRCC value indicating the specific qualitative relationship between the input and the output variable. That is, positive values of PRCC implies that increasing values of the input variable lead to increasing values of the output variable. Since a PRCC indicates the degree of the monotonicity between a specific input variable and a specific output variable, only input variables that are monotonically related to the output variable are included in this analysis <xref ref-type="bibr" rid="pcbi.1003328-Iman1">[32]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-Conover1">[34]</xref>. Hence, we examined the scatterplots between <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e070" xlink:type="simple"/></inline-formula> and each parameter to assess the monotonicity assumption.</p>
<p>We set out to analyze the effectiveness of the various types of control interventions including typical interventions targeting symptomatic infected individuals and novel decolonization strategies focused on the colonized reservoir pediatric population. Specifically, we evaluated reductions in contact rates by infected individuals due to personal awareness of infection. We also assessed the impact of decolonization treatment of infected people following regular antibiotic treatment of MRSA infections. Finally, we examined the possibility of disease elimination by hypothetical decolonization treatment strategies targeting colonized people (in compartment <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e071" xlink:type="simple"/></inline-formula>). We modeled the first intervention by using an age-specific parameter, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e072" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e073" xlink:type="simple"/></inline-formula>, to denote the relative reduction in contact rates between different age groups. Thus, the force of infection given by <xref ref-type="disp-formula" rid="pcbi.1003328.e019">Equation (1g)</xref> becomes<disp-formula id="pcbi.1003328.e074"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003328.e074" xlink:type="simple"/><label>(2)</label></disp-formula>The decolonization treatment targeting symptomatic infected individuals was modeled by varying the decolonization treatment coverage <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e075" xlink:type="simple"/></inline-formula> (in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e076" xlink:type="simple"/></inline-formula>), for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e077" xlink:type="simple"/></inline-formula>. The effect of decolonization treatment for colonized people was modeled by adding an additional age-specific rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e078" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e079" xlink:type="simple"/></inline-formula>, to the spontaneous decolonization rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e080" xlink:type="simple"/></inline-formula>, as the new transition rate from <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e081" xlink:type="simple"/></inline-formula> to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e082" xlink:type="simple"/></inline-formula> (<xref ref-type="fig" rid="pcbi-1003328-g001">Figure 1</xref>). Parameter <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e083" xlink:type="simple"/></inline-formula> is the product of decolonization coverage (age-specific) and reciprocal of duration of drug effect (2 weeks <xref ref-type="bibr" rid="pcbi.1003328-Doebbeling1">[10]</xref>, common across age groups) by assuming perfect drug efficacy. We estimated the associated reduction in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e084" xlink:type="simple"/></inline-formula> and determined whether infections approached zero as we varied the age-specific decolonization coverage.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Model-based estimates</title>
<p>Model parameter estimates and their corresponding geweke indices are shown in <xref ref-type="table" rid="pcbi-1003328-t002">Table 2</xref>. Overall the model yielded a good fit to the incidence curve covering the period 2005–2006 albeit three of the parameter estimates did not achieve high convergence based on their geweke indices (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e085" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e086" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e087" xlink:type="simple"/></inline-formula>) (<xref ref-type="fig" rid="pcbi-1003328-g003">Figure 3</xref>). Moreover, the model forecast for two subsequent years 2007–2008 tracked closely the additional incidence data.</p>
<fig id="pcbi-1003328-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.g003</object-id><label>Figure 3</label><caption>
<title>Model fit to MRSA infection data using MCMC toolbox.</title>
<p>The wider band shows 95% probability limits for individual observations, the darker narrower band shows 95% probability limit for mean prediction and the black curve in the middle is the median prediction. Little squares are data points; the vertical dashed line indicates the calibration period (2004–2006) and the validation period (2007–2008).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.g003" position="float" xlink:type="simple"/></fig><table-wrap id="pcbi-1003328-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.t002</object-id><label>Table 2</label><caption>
<title>Statistics for estimated parameters based on the Markov chain generated by the adaptive Metropolis Hastings algorithm with 2004–2006 data.</title>
</caption><alternatives><graphic id="pcbi-1003328-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Parameter</td>
<td align="left" rowspan="1" colspan="1">mean</td>
<td align="left" rowspan="1" colspan="1">std</td>
<td align="left" rowspan="1" colspan="1">geweke</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e088" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.0021</td>
<td align="left" rowspan="1" colspan="1">0.00026</td>
<td align="left" rowspan="1" colspan="1">0.70</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e089" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.40</td>
<td align="left" rowspan="1" colspan="1">0.081</td>
<td align="left" rowspan="1" colspan="1">0.48</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e090" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.19</td>
<td align="left" rowspan="1" colspan="1">0.058</td>
<td align="left" rowspan="1" colspan="1">0.31</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e091" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.59</td>
<td align="left" rowspan="1" colspan="1">0.082</td>
<td align="left" rowspan="1" colspan="1">0.85</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e092" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.014</td>
<td align="left" rowspan="1" colspan="1">0.0017</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e093" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">1.85</td>
<td align="left" rowspan="1" colspan="1">0.075</td>
<td align="left" rowspan="1" colspan="1">0.92</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e094" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">1.93</td>
<td align="left" rowspan="1" colspan="1">0.043</td>
<td align="left" rowspan="1" colspan="1">0.94</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e095" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">1.80</td>
<td align="left" rowspan="1" colspan="1">0.14</td>
<td align="left" rowspan="1" colspan="1">0.93</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e096" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">1.18</td>
<td align="left" rowspan="1" colspan="1">0.21</td>
<td align="left" rowspan="1" colspan="1">0.53</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e097" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">0.093</td>
<td align="left" rowspan="1" colspan="1">0.0047</td>
<td align="left" rowspan="1" colspan="1">0.92</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e098" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">459</td>
<td align="left" rowspan="1" colspan="1">90</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e099" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">270</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt102"><label/><p>The geweke index closes to 1 means good convergence of the MCMC chain for that parameter.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b">
<title>Uncertainty and sensitivity analysis for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e100" xlink:type="simple"/></inline-formula></title>
<p>We estimated the control reproduction number <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e101" xlink:type="simple"/></inline-formula> using Equation (S2). which we derived using the next generation matrix method <xref ref-type="bibr" rid="pcbi.1003328-Diekmann2">[35]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-VandenDriessche1">[36]</xref> (<xref ref-type="supplementary-material" rid="pcbi.1003328.s004">Text S2</xref>).Parameters <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e102" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e103" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e104" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e105" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e106" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e107" xlink:type="simple"/></inline-formula> satisfied the monotonicity assumption and the corresponding PRCCs are shown in <xref ref-type="fig" rid="pcbi-1003328-g004">Figure 4B</xref>. We found that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e108" xlink:type="simple"/></inline-formula> is most sensitive to the parameters <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e109" xlink:type="simple"/></inline-formula> (progression rate from colonized to infected) followed by <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e110" xlink:type="simple"/></inline-formula> (reciprocal of the duration of being infected). <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e111" xlink:type="simple"/></inline-formula> is also fairly sensitive to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e112" xlink:type="simple"/></inline-formula> (spontaneous decolonization rate). All of them are significant from zero at the 0.001 level according to their p-values.</p>
<fig id="pcbi-1003328-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.g004</object-id><label>Figure 4</label><caption>
<title>Uncertainty and sensitivity analyses on the control reproduction number <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e113" xlink:type="simple"/></inline-formula>.</title>
<p>Histogram of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e114" xlink:type="simple"/></inline-formula> (A) and PRCC of parameters with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e115" xlink:type="simple"/></inline-formula> (B) with parameter uncertainty (based on a random sample of size 500 of Markov chain for parameters).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.g004" position="float" xlink:type="simple"/></fig></sec><sec id="s3c">
<title>Evaluating the effect of intervention strategies</title>
<sec id="s3c1">
<title>The effectiveness of reducing contact rates by infected individuals</title>
<p>In order to assess the impact of contact rate reductions by infected individuals across different age groups, we used mean estimates of model parameters as given in <xref ref-type="table" rid="pcbi-1003328-t002">Table 2</xref>. We drew a random sample of parameters <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e116" xlink:type="simple"/></inline-formula> of size 100 from its 6-dimensional uniform distribution using LHS to calculate the distribution of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e117" xlink:type="simple"/></inline-formula> and the corresponding PRCCs of each of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e118" xlink:type="simple"/></inline-formula>'s. As expected, the greater the reduction in contact rate by infected individuals the higher the reduction in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e119" xlink:type="simple"/></inline-formula>, with the age group 10–14 yrs being slightly more influential on reducing <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e120" xlink:type="simple"/></inline-formula> relative to other age groups. Specifically, we estimated the reduction levels in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e121" xlink:type="simple"/></inline-formula> as we decreased the contact rates from 0 to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e122" xlink:type="simple"/></inline-formula> among infected individuals aged <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e123" xlink:type="simple"/></inline-formula> yrs (<xref ref-type="fig" rid="pcbi-1003328-g005">Figure 5A2</xref>) or across all age groups (<xref ref-type="fig" rid="pcbi-1003328-g005">Figure 5A3</xref>). For instance, mean <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e124" xlink:type="simple"/></inline-formula> was reduced by only 1.0% when infected individuals aged 10–14 yrs did not make contacts with other individuals while <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e125" xlink:type="simple"/></inline-formula> was reduced by <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e126" xlink:type="simple"/></inline-formula> in the scenario that all infected individuals across all age groups did not make contacts with others.</p>
<fig id="pcbi-1003328-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.g005</object-id><label>Figure 5</label><caption>
<title>PRCC and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e127" xlink:type="simple"/></inline-formula> under different intervention strategies.</title>
<p>Upper panel: PRCC of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e128" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e129" xlink:type="simple"/></inline-formula>, level of contact reduction in age group <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e130" xlink:type="simple"/></inline-formula>), with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e131" xlink:type="simple"/></inline-formula> based on a sample of size 100 using LHS (A1); <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e132" xlink:type="simple"/></inline-formula> for different levels of contact reduction under uncertainty of other model parameters (A2); and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e133" xlink:type="simple"/></inline-formula> for different level of population-wide contact reduction under the uncertainty of other parameters(A3). Lower panel: PRCC of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e134" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e135" xlink:type="simple"/></inline-formula>, decolonization treatment coverage in age group <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e136" xlink:type="simple"/></inline-formula>), with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e137" xlink:type="simple"/></inline-formula> based on a sample of size 100 using LHS (B1); <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e138" xlink:type="simple"/></inline-formula> for different levels of decolonization treatment coverage under uncertainty of other model parameters (B2); and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e139" xlink:type="simple"/></inline-formula> for different levels of population-wide decolonization treatment coverage under the uncertainty of other parameters (B3).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.g005" position="float" xlink:type="simple"/></fig></sec><sec id="s3c2">
<title>Evaluating the effect of decolonization treatment on infected individuals</title>
<p>To examine the effect of decolonization treatment strategies targeting symptomatic infected individuals, we quantified the sensitivity of each age-specific decolonization coverage <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e140" xlink:type="simple"/></inline-formula> on <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e141" xlink:type="simple"/></inline-formula>. We found that All PRCCs across age groups for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e142" xlink:type="simple"/></inline-formula>s followed the same pattern (<xref ref-type="fig" rid="pcbi-1003328-g005">Figure 5B1</xref>) except for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e143" xlink:type="simple"/></inline-formula>, the decolonization treatment coverage for the 6th age group (60+ yrs.), which showed no monotonic relation with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e144" xlink:type="simple"/></inline-formula> (not shown in <xref ref-type="fig" rid="pcbi-1003328-g005">Figure 5B1</xref>). The mean <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e145" xlink:type="simple"/></inline-formula> decreased by 2.1% when all infected individuals aged 10–14 yrs were treated by decolonization drugs for regular antibiotic treatment for CA-MRSA infections (<xref ref-type="fig" rid="pcbi-1003328-g005">Figure 5B2</xref>) while <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e146" xlink:type="simple"/></inline-formula> was reduced by 7.8% when all infected individuals across all age groups were treated by decolonization drugs (<xref ref-type="fig" rid="pcbi-1003328-g005">Figure 5B3</xref>). We found that decolonization treatment strategies targeting symptomatic infected individuals were not sufficient to achieve disease control. Simulations of decolonization treatment strategies targeting all infected individuals in pediatric age groups or across all age groups are shown in <xref ref-type="fig" rid="pcbi-1003328-g006">Figure 6</xref>. We found that recurrent infections were essentially brought under control, but first-time infections remained well above zero even when all infected individuals across all age groups underwent decolonization treatment.</p>
<fig id="pcbi-1003328-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.g006</object-id><label>Figure 6</label><caption>
<title>Model prediction for first-time and recurrent infections for pediatric groups until December 2023 with mean parameter values and different decolonization treatment coverage after 2008.</title>
<p>100% coverage for the first 4 age groups and 0 for adult groups (slim lines); 2). 100% coverage for the whole population (bold lines). The age-specific decolonization treatment coverage for till 2008 are time-dependent step functions with extreme values given by <xref ref-type="supplementary-material" rid="pcbi.1003328.s002">Table S1</xref> for 4 pediatric groups and 0 for 2 adult groups.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.g006" position="float" xlink:type="simple"/></fig></sec><sec id="s3c3">
<title>Effectiveness of combinations of the two strategies targeting symptomatic infected people</title>
<p>We assessed if a combination control strategy that includes reduction in contact rates by infected individuals with others and decolonization treatment for infected individuals was capable of achieving disease control. The effective values of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e147" xlink:type="simple"/></inline-formula> as a function of different reduction levels in contact rates by infected individuals and different levels of decolonization treatment coverage targeting symptomatic infected individuals across all age groups are shown in <xref ref-type="fig" rid="pcbi-1003328-g007">Figure 7</xref>. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e148" xlink:type="simple"/></inline-formula> was no less than 1.18 under the combination of two strategies regardless of their intensity levels. In addition, the long term effect of single or combined intervention strategies on disease levels are illustrated in <xref ref-type="table" rid="pcbi-1003328-t003">Table 3</xref>. It shows that decolonization treatment for the infected reduced much more total infections in the pediatric population than reducing contacts of infected people did, and a combination control strategy implementing both intervention strategies was not sufficient to achieve disease eradication.</p>
<fig id="pcbi-1003328-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.g007</object-id><label>Figure 7</label><caption>
<title>Mean value of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e149" xlink:type="simple"/></inline-formula> for a combined strategy of with different levels of reduction in contact of infected individuals (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e150" xlink:type="simple"/></inline-formula>) and decolonization treatment coverage the infected (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e151" xlink:type="simple"/></inline-formula>) in all age groups under parameter uncertainty.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.g007" position="float" xlink:type="simple"/></fig><table-wrap id="pcbi-1003328-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.t003</object-id><label>Table 3</label><caption>
<title>Model-based forecast of the number of first-time infections (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e152" xlink:type="simple"/></inline-formula>)and recurrent infections (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e153" xlink:type="simple"/></inline-formula>) for the first age groups (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e154" xlink:type="simple"/></inline-formula>), and reduction of total infections in the pediatric population (0–19 years) compared with baseline (no intervention) at the end of 2023 under different population-wide intervention strategies.</title>
</caption><alternatives><graphic id="pcbi-1003328-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Strategy</td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sub>01</sub></td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sub>02</sub></td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sub>03</sub></td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sub>04</sub></td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sub>11</sub></td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sub>12</sub></td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sub>13</sub></td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sub>14</sub></td>
<td align="left" rowspan="1" colspan="1">total reduction</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Baseline</td>
<td align="left" rowspan="1" colspan="1">150</td>
<td align="left" rowspan="1" colspan="1">133</td>
<td align="left" rowspan="1" colspan="1">137</td>
<td align="left" rowspan="1" colspan="1">143</td>
<td align="left" rowspan="1" colspan="1">182</td>
<td align="left" rowspan="1" colspan="1">146</td>
<td align="left" rowspan="1" colspan="1">172</td>
<td align="left" rowspan="1" colspan="1">312</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Strategy 1</td>
<td align="left" rowspan="1" colspan="1">128</td>
<td align="left" rowspan="1" colspan="1">116</td>
<td align="left" rowspan="1" colspan="1">121</td>
<td align="left" rowspan="1" colspan="1">126</td>
<td align="left" rowspan="1" colspan="1">124</td>
<td align="left" rowspan="1" colspan="1">104</td>
<td align="left" rowspan="1" colspan="1">125</td>
<td align="left" rowspan="1" colspan="1">214</td>
<td align="left" rowspan="1" colspan="1">23%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Strategy 2</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">27</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">91%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Strategy 1 and 2</td>
<td align="left" rowspan="1" colspan="1">19</td>
<td align="left" rowspan="1" colspan="1">19</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">94%</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt103"><label/><p>Strategy 1: 100% reduction in contact of infected with others; Strategy 2: decolonization treatment for all infected.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c4">
<title>Evaluating the impact of decolonization treatment strategies targeting colonized people</title>
<p>Whereas routine intervention strategies targeting symptomatic infected individuals were not found to be capable of achieving disease control, we also evaluated the impact of hypothetical intervention strategies targeting colonized (asymptomatic) individuals (compartment <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e155" xlink:type="simple"/></inline-formula> in <xref ref-type="fig" rid="pcbi-1003328-g001">Figure 1</xref>). We found that treatment of colonized asymptomatic individuals in any single age group was not enough to achieve disease control. However, by exploring decolonization treatment targeting combinations of two pediatric age groups, we found that decolonization treatment targeting colonized individuals in age groups 5–9 and 10–14 yrs. achieved <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e156" xlink:type="simple"/></inline-formula> whenever coverage levels <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e157" xlink:type="simple"/></inline-formula> (<xref ref-type="fig" rid="pcbi-1003328-g008">Figure 8</xref>). By targeting colonized people across 4 pediatric age groups, we also found that the minimum decolonization treatment coverage necessary to achieve <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e158" xlink:type="simple"/></inline-formula> was <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e159" xlink:type="simple"/></inline-formula>. The long-term disease dynamics forecasts with decolonization treatment coverage at 30% implemented continuously starting in year 2009 on age groups 5–9 and 10–14 yrs. and across all pediatric groups are shown in <xref ref-type="fig" rid="pcbi-1003328-g009">Figure 9</xref>. Findings indicated that targeting individuals aged 5–14 yrs. required 20 years to achieve disease elimination while disease control could be achieved within 5 years when the intervention was focused on all pediatric groups.</p>
<fig id="pcbi-1003328-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.g008</object-id><label>Figure 8</label><caption>
<title>Mean <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e160" xlink:type="simple"/></inline-formula> with different levels of decolonization treatment coverage for colonized people in various combinations of two of pediatric groups.</title>
<p>The error bars are based on standard deviations of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e161" xlink:type="simple"/></inline-formula>s under parameter uncertainty.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.g008" position="float" xlink:type="simple"/></fig><fig id="pcbi-1003328-g009" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003328.g009</object-id><label>Figure 9</label><caption>
<title>Long-term forecast of CA-MRSA infections in the pediatric groups under decolonization treatment strategy targeting colonized people with 30% coverage in different age groups.</title>
<p>5–9 and 10–14 yrs. age groups (upper panel); all pediatric groups (lower panel).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003328.g009" position="float" xlink:type="simple"/></fig></sec></sec></sec><sec id="s4">
<title>Discussion</title>
<p>We have developed and parameterized the first age-structured model of the transmission dynamics of MRSA transmission at the community level using data on skin and soft tissue infections in children and teenagers who were enrolled in the Medicaid Program in Maricopa County, Arizona. Our compartmental epidemic model includes age heterogeneity in contact rates, infectiousness, and decolonization treatment rates, and keeps track of individuals with past infection history. We estimated the control reproduction number at 1.3 with 95% confidence interval [1.2, 1.4]. Sensitivity analysis of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e162" xlink:type="simple"/></inline-formula> on the model parameters revealed that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e163" xlink:type="simple"/></inline-formula> is most sensitive to the parameters <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e164" xlink:type="simple"/></inline-formula> (progression rate from colonized to infected) followed by <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e165" xlink:type="simple"/></inline-formula> (reciprocal of the duration of being infected) and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e166" xlink:type="simple"/></inline-formula> (spontaneous decolonization rate). Using our calibrated model, we found that typical strategies focused on infected individuals were not capable of achieving disease control when implemented alone or in combination. In contrast, our results suggest that novel decolonization strategies that target the general pediatric population colonized with CA-MRSA have the potential of achieving disease elimination.</p>
<p>We performed numerical simulations to explore the impact of various feasible intervention strategies such as reductions in contact rates by infected people owing to personal awareness of infection and effect of decolonization treatment targeting symptomatic infected individuals belonging to specific age groups or across the entire population. We found that neither a single or combined strategy was able to achieve <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e167" xlink:type="simple"/></inline-formula>. We also forecasted short-term disease dynamics in the presence of both types of interventions strategies starting in 2009. Our results suggest that reductions in contact rates by infected people has little effect on the disease prevalence, and that neither of the two strategies was capable of achieving disease control particularly among first-time infections. Given that these two intervention strategies are the most widely practiced (intuitively and clinically), our model-based results provide an explanation to the persistent levels of CA-MRSA in many US regions over 20 years since its first appearance <xref ref-type="bibr" rid="pcbi.1003328-Purcell1">[3]</xref>–<xref ref-type="bibr" rid="pcbi.1003328-Pallin1">[6]</xref>. We also tested the effectiveness of some hypothetical decolonization treatment strategies targeting asymptomatic colonized people. We found that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e168" xlink:type="simple"/></inline-formula> could be reduced below 1 when the treatment was focused on 5–9 and 10–14 yrs. age groups with coverage at 25%, and an even smaller coverage (5%) was sufficient when all pediatric groups groups were targeted. Long-term forecast of the infections showed that disease elimination is feasible within 5 years through decolonization treatment at 30% of colonized people in the pediatric population starting in 2009.</p>
<p>Compared with published models on MRSA transmission, our model is novel in several ways. First, our model accounts for transmission in a heterogeneous population based on age-specific contact rates calibrated using survey data on physical contacts <xref ref-type="bibr" rid="pcbi.1003328-Mossong1">[25]</xref>. This enables our model to capture much more essential elements of the complex MRSA transmission problem and test the effect of different control strategies that target different age groups. Second, our model was calibrated and provided a good fit to time series data using solid estimation techniques rather than solely relying on assumed parameter values from the literature. It is worth mentioning that our estimate of the control reproduction number at 1.3 is in line with that assumed in prior studies (e.g., <xref ref-type="bibr" rid="pcbi.1003328-Cooper1">[37]</xref>). Moreover, it important to note that while our model incorporates key features of the transmission process including a realistic population contact structure and dominant features of MRSA epidemiology, there are many limitations to policy models with respect to the incorporation of bio-medical, operational, political, and economic features. No one model can claim to incorporate all assumptions and features given the limited data available to calibrate them. We believe our transmission model could be useful to evaluate further control scenarios and formulate rational policy based on the best available evidence.</p>
<p>There are limitations to note about our model calibration. Some of the Markov chains did not converge perfectly within 10000 steps in terms of the geweke index. However, our objective here was to find reasonable values of parameters so that our model captured qualitatively the overall trend of the age-specific time series data. In this sense, the MCMC algorithm worked much better than other sampling methods (e.g., Latin Hypercube Sampling or simple random sampling with repetition). Moreover, we also calculated the R-squared(<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e169" xlink:type="simple"/></inline-formula>), a widely-used index for goodness of fit for a general model, for each of the eight output variables, and it turned out that the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e170" xlink:type="simple"/></inline-formula>s for first-time infections were much poorer (less than 0.5) than those for the recurrent infections (greater than 0.7). Hence, our model did a better job in modeling recurrent infections than first time infections. Of note, our model described by System (1) does not account for seasonality patterns <xref ref-type="bibr" rid="pcbi.1003328-Wang1">[38]</xref>, which may explain a significant fraction of variation in data that remained unexplained by the model. Moreover, we did not account for the changing medical practice as our understanding of this pathogen has increased since 2004. The infection duration decreased over these years as the appropriate antibiotics changed from second line medications to first line medications <xref ref-type="bibr" rid="pcbi.1003328-Olesevich1">[39]</xref>–<xref ref-type="bibr" rid="pcbi.1003328-Marra1">[41]</xref>. Therefore the model prediction might have overestimated the infection prevalence.</p>
<p>Our dataset itself has several limitations. First, our data correspond to general SSTIs which may not be directly related to CA-MRSA. However, it has been observed from microbiological analyses that the fraction of MRSA-related SSTIs remained stationary among the total SSTIs in our study population for our study period <xref ref-type="bibr" rid="pcbi.1003328-Panchanathan1">[24]</xref>. Given that it will be difficult to truly determine the exact cases of MRSA-related SSTIs and their microbiological spectrum at the population level, our data set is the best among those available. Second, the target population of the data set corresponds to the children and young adults in the Medicaid program in Maricopa County, AZ. It is important to note that patients under Medicaid coverage belong to a lower income population, where the rate of infection has been described to be higher than that of the general population<xref ref-type="bibr" rid="pcbi.1003328-Bratu1">[5]</xref>, <xref ref-type="bibr" rid="pcbi.1003328-Fritz1">[42]</xref>. Hence, our model prediction likely overestimates the prevalence in the overall population in Maricopa County. Further studies are needed to shed light on whether our findings can be generalized to other settings.</p>
<p>In summary, our model indicates that intervention strategies targeting only infected people, either by reducing their contact frequency with healthy people or by pharmaceutical decolonization are not capable of eliminating CA-MRSA infections at the population level. By contrast, substantial reductions in the prevalence of HA-MRSA could be achieved via contact reductions via patient isolation, enhanced hand hygiene and screening and health-care worker cohorting strategies (e.g., <xref ref-type="bibr" rid="pcbi.1003328-Wang2">[43]</xref>). Our control scenarios based on decolonization treatment strategies that target asymptomatic colonized individuals indicate that finding a cost-effective method to locate colonized individuals and conducting decolonization treatment on a limited fraction of them could prove to be an effective intervention. However, the possibility of resistance emerging from increased use of mupirocin cannot be overemphasized. Future modeling studies could be carried out to to evaluate the effect of strategies aimed at reducing the impact of resistance emerging from large-scale use of mupirocin. Moreover, further work should focus on the collection of morbidity data and quantification of the attack rates and transmission dynamics of CA-MRSA in other world settings with different socio-economic and climatic characteristics. While our transmission model is based on key epidemiological features of CA-MRSA including age-specific heterogeneity in contact rates, infectiousness and decolonization treatment rates, predictions from more elaborate models that incorporate, for instance, seasonality in transmission efficiency or a more detailed picture of the transmission process (e.g., household level transmission models) could be undertaken in future work as relevant epidemiological data become available.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1003328.s001" mimetype="application/vnd.ms-excel" xlink:href="info:doi/10.1371/journal.pcbi.1003328.s001" position="float" xlink:type="simple"><label>Dataset S1</label><caption>
<p>Data set used for model calibration and validation.</p>
<p>(XLS)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003328.s002" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003328.s002" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p>Average decolonization treatment rate estimated for two time periods from variable ‘rx’ in Dataset S1.</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003328.s003" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003328.s003" position="float" xlink:type="simple"><label>Text S1</label><caption>
<p>Description of Dataset S1 and data manipulation.</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003328.s004" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003328.s004" position="float" xlink:type="simple"><label>Text S2</label><caption>
<p>Mathematical deduction of control reproduction number (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003328.e171" xlink:type="simple"/></inline-formula>).</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003328.s005" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003328.s005" position="float" xlink:type="simple"><label>Text S3</label><caption>
<p>Description of model calibration using MCMC technique.</p>
<p>(PDF)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pcbi.1003328-Lowy1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lowy</surname><given-names>FD</given-names></name> (<year>1998</year>) <article-title>Staphylococcus aureus infections</article-title>. <source>New England Journal of Medicine</source> <volume>339</volume>: <fpage>520</fpage>–<lpage>532</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Jevons1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jevons</surname><given-names>MP</given-names></name> (<year>1961</year>) <article-title>“celbenin”-resistant staphylococci</article-title>. <source>British Medical Journal</source> <volume>1</volume>: <fpage>124</fpage>–<lpage>125</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Purcell1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Purcell</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fergie</surname><given-names>JE</given-names></name> (<year>2002</year>) <article-title>Exponential increase in community-acquired methicillin-resistant staphylococcus aureus infections in south texas children</article-title>. <source>The Pediatric infectious disease journal</source> <volume>21</volume>: <fpage>988</fpage>–<lpage>989</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Dukic1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dukic</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Lauderdale</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Wilder</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Daum</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>David</surname><given-names>MZ</given-names></name> (<year>2013</year>) <article-title>Epidemics of community-associated methicillin-resistant staphylococcus aureus in the united states: A meta-analysis</article-title>. <source>PloS one</source> <volume>8</volume>: <fpage>e52722</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Bratu1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bratu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Landman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Trehan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Panwar</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>A population-based study examining the emergence of community-associated methicillin-resistant staphylococcus aureus usa300 in new york city</article-title>. <source>Annals of clinical microbiology and antimicrobials</source> <volume>5</volume>: <fpage>29</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Pallin1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pallin</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Egan</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Pelletier</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Espinola</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Hooper</surname><given-names>DC</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Increased us emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant staphylococcus aureus</article-title>. <source>Annals of emergency medicine</source> <volume>51</volume>: <fpage>291</fpage>–<lpage>298</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Popovich1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Popovich</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Hota</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Aroutcheva</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kurien</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Community-associated methicillin-resistant staphylococcus aureus colonization burden in hiv-infected patients</article-title>. <source>Clinical Infectious Diseases</source> <volume>56</volume>: <fpage>1067</fpage>–<lpage>74</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Naimi1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naimi</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>LeDell</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Como-Sabetti</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Borchardt</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Boxrud</surname><given-names>DJ</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Comparison of community-and health care–associated methicillin-resistant staphylococcus aureus infection</article-title>. <source>JAMA: the journal of the American Medical Association</source> <volume>290</volume>: <fpage>2976</fpage>–<lpage>2984</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-David1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>David</surname><given-names>MZ</given-names></name>, <name name-style="western"><surname>Daum</surname><given-names>RS</given-names></name> (<year>2010</year>) <article-title>Community-associated methicillin-resistant staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic</article-title>. <source>Clinical Microbiology Reviews</source> <volume>23</volume>: <fpage>616</fpage>–<lpage>687</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Doebbeling1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doebbeling</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Reagan</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Pfaller</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Houston</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Hollis</surname><given-names>RJ</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>Long-term efficacy of intranasal mupirocin ointment: a prospective cohort study of staphylococcus aureus carriage</article-title>. <source>Archives of internal medicine</source> <volume>154</volume>: <fpage>1505</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Perl1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Perl</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Cullen</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Wenzel</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Zimmerman</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Pfaller</surname><given-names>MA</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Intranasal mupirocin to prevent postoperative staphylococcus aureus infections</article-title>. <source>New England Journal of Medicine</source> <volume>346</volume>: <fpage>1871</fpage>–<lpage>1877</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-VanRijen1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van Rijen</surname><given-names>M</given-names></name> (<year>2009</year>) <article-title>Mupirocin ointment for preventing staphylococcus aureus infections in nasal carriers</article-title>. <source>Journal of Evidence-Based Medicine</source> <volume>2</volume>: <fpage>129</fpage>–<lpage>129</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-MCDAgata1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>MC D'Agata</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Horn</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Moellering</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Ruan</surname><given-names>S</given-names></name> (<year>2009</year>) <article-title>Modeling the invasion of community-acquired methicillin-resistant staphylococcus aureus into hospitals</article-title>. <source>Clinical Infectious Diseases</source> <volume>48</volume>: <fpage>274</fpage>–<lpage>284</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-DAgata1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DAgata</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Pressley</surname><given-names>J</given-names></name> (<year>2010</year>) <article-title>Rapid emergence of co-colonization with community-acquired and hospital-acquired methicillin-resistant staphylococcus aureus strains in the hospital setting</article-title>. <source>Mathematical modelling of natural phenomena</source> <volume>5</volume>: <fpage>76</fpage>–<lpage>93</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Lee1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>BY</given-names></name>, <name name-style="western"><surname>McGlone</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Yilmaz</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Avery</surname><given-names>TR</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Modeling the spread of methicillin-resistant staphylococcus aureus (mrsa) outbreaks throughout the hospitals in orange county, california</article-title>. <source>Infection Control and Hospital Epidemiology</source> <volume>32</volume>: <fpage>562</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Chamchod1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chamchod</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ruan</surname><given-names>S</given-names></name> (<year>2012</year>) <article-title>Modeling methicillin-resistant staphylococcus aureus in hospitals: Transmission dynamics, antibiotic usage and its history</article-title>. <source>Theoretical Biology and Medical Modelling</source> <volume>9</volume>: <fpage>25</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Chamchod2"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chamchod</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ruan</surname><given-names>S</given-names></name> (<year>2012</year>) <article-title>Modeling the spread of methicillin-resistant staphylococcus aureus in nursing homes for elderly</article-title>. <source>PloS One</source> <volume>7</volume>: <fpage>e29757</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Wassenberg1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wassenberg</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>De Wit</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Van Hout</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Bonten</surname><given-names>MJ</given-names></name> (<year>2010</year>) <article-title>Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of mrsa</article-title>. <source>PloS one</source> <volume>5</volume>: <fpage>e11562</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Kouyos1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kouyos</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Grenfell</surname><given-names>B</given-names></name> (<year>2013</year>) <article-title>Hospital-community interactions foster coexistence between methicillin-resistant strains of staphylococcus aureus</article-title>. <source>PLoS pathogens</source> <volume>9</volume>: <fpage>e1003134</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Milstone1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Milstone</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Goldner</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Shepard</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Carroll</surname><given-names>KC</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Methicillin-resistant staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant staphylococcus aureus transmission</article-title>. <source>Clinical infectious diseases</source> <volume>53</volume>: <fpage>853</fpage>–<lpage>859</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Macdonald1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Macdonald</surname><given-names>G</given-names></name> (<year>1961</year>) <article-title>Epidemiologic models in studies of vetor-borne diseases: The re dyer lecture</article-title>. <source>Public health reports</source> <volume>76</volume>: <fpage>753</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Anderson1"><label>22</label>
<mixed-citation publication-type="book" xlink:type="simple">Anderson R, May R (1991) Infectious diseases of humans. Oxford University Press.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Diekmann1"><label>23</label>
<mixed-citation publication-type="book" xlink:type="simple">Diekmann O, Heesterbeek J (2000) Mathematical epidemiology of infectious diseases: model building, analysis and interpretation. John Wiley &amp; Sons.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Panchanathan1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Panchanathan</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Petitti</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Fridsma</surname><given-names>DB</given-names></name> (<year>2010</year>) <article-title>The development and validation of a simulation tool for health policy decision making</article-title>. <source>Journal of Biomedical Informatics</source> <volume>43</volume>: <fpage>602</fpage>–<lpage>607</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Mossong1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mossong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hens</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Jit</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Beutels</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Auranen</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Social contacts and mixing patterns relevant to the spread of infectious diseases</article-title>. <source>PLoS medicine</source> <volume>5</volume>: <fpage>e74</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Medlock1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Medlock</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Galvani</surname><given-names>AP</given-names></name> (<year>2009</year>) <article-title>Optimizing influenza vaccine distribution</article-title>. <source>Science</source> <volume>325</volume>: <fpage>1705</fpage>–<lpage>1708</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Vaska1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vaska</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Nimmo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Grimwood</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Paterson</surname><given-names>D</given-names></name> (<year>2012</year>) <article-title>Increases in australian cutaneous abscess hospitalisations: 1999–2008</article-title>. <source>European journal of clinical microbiology &amp; infectious diseases</source> <volume>31</volume>: <fpage>93</fpage>–<lpage>96</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Fridkin1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fridkin</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Hageman</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sanza</surname><given-names>LT</given-names></name>, <name name-style="western"><surname>Como-Sabetti</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Methicillin-resistant staphylococcus aureus disease in three communities</article-title>. <source>New England Journal of Medicine</source> <volume>352</volume>: <fpage>1436</fpage>–<lpage>1444</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Haario1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haario</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Laine</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mira</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Saksman</surname><given-names>E</given-names></name> (<year>2006</year>) <article-title>Dram: efficient adaptive mcmc</article-title>. <source>Statistics and Computing</source> <volume>16</volume>: <fpage>339</fpage>–<lpage>354</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Calvetti1"><label>30</label>
<mixed-citation publication-type="book" xlink:type="simple">Calvetti D, Somersalo E (2007) Introduction to bayesian scientific computing: ten lectures on subjective computing. Springer.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Blower1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blower</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dowlatabadi</surname><given-names>H</given-names></name> (<year>1994</year>) <article-title>Sensitivity and uncertainty analysis of complex models of disease transmission: an hiv model, as an example</article-title>. <source>International Statistical Review/Revue Internationale de Statistique</source> <volume>62</volume>: <fpage>229</fpage>–<lpage>243</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Iman1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Helton</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>J</given-names></name> (<year>1981</year>) <article-title>An approach to sensitivity analysis of computer-models. 1. introduction, input variable selection and preliminary variable assessment</article-title>. <source>Journal of quality technology</source> <volume>13</volume>: <fpage>174</fpage>–<lpage>183</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-McKay1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McKay</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Beckman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Conover</surname><given-names>W</given-names></name> (<year>1979</year>) <article-title>A comparison of three methods for selecting values of input variables in the analysis of output from a computer code</article-title>. <source>Technometrics</source> <volume>21</volume>: <fpage>239</fpage>–<lpage>245</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Conover1"><label>34</label>
<mixed-citation publication-type="book" xlink:type="simple">Conover W (1980) Practical nonparametric statistics. New York: J Wiley &amp; Sons.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Diekmann2"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Diekmann</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Dietz</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Heesterbeek</surname><given-names>J</given-names></name> (<year>1991</year>) <article-title>The basic reproduction ratio for sexually transmitted diseases: I. theoretical considerations</article-title>. <source>Mathematical biosciences</source> <volume>107</volume>: <fpage>325</fpage>–<lpage>339</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-VandenDriessche1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van den Driessche</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Watmough</surname><given-names>J</given-names></name> (<year>2002</year>) <article-title>Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission</article-title>. <source>Mathematical biosciences</source> <volume>180</volume>: <fpage>29</fpage>–<lpage>48</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Cooper1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cooper</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Medley</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Stone</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kibbler</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cookson</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Methicillin-resistant staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>101</volume>: <fpage>10223</fpage>–<lpage>10228</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Wang1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Towers</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Panchanathan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chowell</surname><given-names>G</given-names></name> (<year>2013</year>) <article-title>A population based study of seasonality of skin and soft tissue infections: Implications for the spread of ca-mrsa</article-title>. <source>Plos one</source> <volume>8</volume>: <fpage>e60872</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Olesevich1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Olesevich</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>A</given-names></name> (<year>2007</year>) <article-title>Emergence of community-acquired methicillin-resistant staphylococcus aureus soft tissue infections</article-title>. <source>Journal of Pediatric Surgery</source> <volume>42</volume>: <fpage>765</fpage>–<lpage>768</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Parnes1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parnes</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Fernald</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Coombs</surname><given-names>L</given-names></name>, <name name-style="western"><surname>DeAlleaume</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Brandt</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Improving the management of skin and soft tissue infections in primary care: a report from state networks of colorado ambulatory practices and partners (snocap-usa) and the distributed ambulatory research in therapeutics network (dartnet)</article-title>. <source>The Journal of the American Board of Family Medicine</source> <volume>24</volume>: <fpage>534</fpage>–<lpage>542</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Marra1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marra</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Patrick</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Chong</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McKay</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hoang</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Population-based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use</article-title>. <source>Antimicrobial agents and chemotherapy</source> <volume>56</volume>: <fpage>6243</fpage>–<lpage>6249</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Fritz1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fritz</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Garbutt</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Elward</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shannon</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Storch</surname><given-names>GA</given-names></name> (<year>2008</year>) <article-title>Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive staphylococcus aureus colonization in children seen in a practice-based research network</article-title>. <source>Pediatrics</source> <volume>121</volume>: <fpage>1090</fpage>–<lpage>1098</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Wang2"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Magal</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhuo</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Modelling the transmission dynamics of meticillin-resistant <italic>staphylococcus aureus</italic> in beijing tongren hospital</article-title>. <source>Journal of Hospital Infection</source> <volume>79</volume>: <fpage>302</fpage>–<lpage>308</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-McBryde1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McBryde</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bradley</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Whitby</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McElwain</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>An investigation of contact transmission of methicillin-resistant staphylococcus aureus</article-title>. <source>The Journal of hospital infection</source> <volume>58</volume>: <fpage>104</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Marschall1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marschall</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mühlemann</surname><given-names>K</given-names></name> (<year>2006</year>) <article-title>Duration of methicillin-resistant staphylococcus aureus carriage, according to risk factors for acquisition</article-title>. <source>Infection control and hospital epidemiology</source> <volume>27</volume>: <fpage>1206</fpage>–<lpage>1212</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Konvalinka1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Konvalinka</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Errett</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fong</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Impact of treating staphylococcus aureus nasal carriers on wound infections in cardiac surgery</article-title>. <source>The Journal of hospital infection</source> <volume>64</volume>: <fpage>162</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Coates1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coates</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bax</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Coates</surname><given-names>A</given-names></name> (<year>2009</year>) <article-title>Nasal decolonization of staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects</article-title>. <source>Journal of Antimicrobial Chemotherapy</source> <volume>64</volume>: <fpage>9</fpage>–<lpage>15</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Ellis1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ellis</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Griffith</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Dooley</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>McLean</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Jorgensen</surname><given-names>JH</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant staphylococcus aureus strains in soldiers: a cluster randomized controlled trial</article-title>. <source>Antimicrobial agents and chemotherapy</source> <volume>51</volume>: <fpage>3591</fpage>–<lpage>3598</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Salgado1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salgado</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Farr</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Calfee</surname><given-names>DP</given-names></name> (<year>2003</year>) <article-title>Community-acquired methicillin-resistant staphylococcus aureus: a meta-analysis of prevalence and risk factors</article-title>. <source>Clinical Infectious Diseases</source> <volume>36</volume>: <fpage>131</fpage>–<lpage>139</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003328-Bureau1"><label>50</label>
<mixed-citation publication-type="other" xlink:type="simple">Bureau USC (2004). Population data. Available: <ext-link ext-link-type="uri" xlink:href="http://www.census.gov/popest" xlink:type="simple">http://www.census.gov/popest</ext-link>.</mixed-citation>
</ref>
</ref-list></back>
</article>